Author

Loes Nissen

WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY
WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY

Loes Nissen  et al.

A HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATE 3 CONCENTRATION IS ASSOCIATED WITH METHOTREXATE DRUG-SURVIVAL IN PATIENTS WITH CROHN’S DISEASE
A HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATE 3 CONCENTRATION IS ASSOCIATED WITH METHOTREXATE DRUG-SURVIVAL IN PATIENTS WITH CROHN’S DISEASE

Loes Nissen  et al.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

Loes Nissen  et al.

METHOTREXATE POLYGLUTAMATE CONCENTRATIONS IN TARGET COLONIC MUCOSA, AND WHITE BLOOD CELLS COMPARED TO NON-TARGET RED BLOOD CELLS OF PATIENTS WITH CROHN’S DISEASE
METHOTREXATE POLYGLUTAMATE CONCENTRATIONS IN TARGET COLONIC MUCOSA, AND WHITE BLOOD CELLS COMPARED TO NON-TARGET RED BLOOD CELLS OF PATIENTS WITH CROHN’S DISEASE

Loes Nissen  et al.

Item 1 - 4 / 4
1